Cancer Family
Cystic Neoplasm
CI-CAN-00000011Explore in graph →
Non-malignant36 active trials1 evidence items
- NCIt
- C6784
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000011Explore in graph →
Clinical trials
163 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07845994 | SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years(SEMAFORCRANIO) | not yet recruiting | Phase 3 | 50 | University Hospital, AngersOTHER_GOV | 1 | Sep 29, 2026 | clinicaltrials |
| NCT01247597 | DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study | recruiting | — | 1,500 | National Cancer Institute (NCI)NIH |
| 1 |
| Sep 28, 2026 |
| clinicaltrials |
| NCT02792582 | A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection | active not recruiting | Phase 2 | 160 | St. Jude Children's Research HospitalOTHER | 1 | Sep 22, 2026 | clinicaltrials |
| NCT04291651 | UCSF PANC Cyst Registry(UCSF PCR) | recruiting | — | 4,000 | University of California, San FranciscoOTHER | 1 | Sep 22, 2026 | clinicaltrials |
| NCT07835165 | A Comparative Study Evaluating the Impact of Intensive Dietary Care on Weight Change and Biological Parameters in Patients Who Underwent Surgery for Craniopharyngioma During the First Postoperative Year(CRANIODIET) | not yet recruiting | N/A | 75 | Assistance Publique Hopitaux De MarseilleOTHER | 0 | Sep 22, 2026 | clinicaltrials |
| NCT02101775 | Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | active not recruiting | Phase 2 | 124 | National Cancer Institute (NCI)NIH | 3 | Sep 10, 2026 | clinicaltrials |
| NCT07809178 | China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm(ChTTSRUIA) | not yet recruiting | — | 608 | Cheng senOTHER | 1 | Sep 9, 2026 | clinicaltrials |
| NCT04207944 | The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) | active not recruiting | Phase 2 | 100 | Duke UniversityOTHER | 1 | Sep 8, 2026 | clinicaltrials |
| NCT01081262 | Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer | active not recruiting | Phase 3 | 50 | National Cancer Institute (NCI)NIH | 1 | Aug 28, 2026 | clinicaltrials |
| NCT02142803 | TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors | active not recruiting | Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Aug 28, 2026 | clinicaltrials |
| NCT01419067 | A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection | active not recruiting | Phase 2 | 112 | St. Jude Children's Research HospitalOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT05919264 | FOG-001 in Locally Advanced or Metastatic Solid Tumors | recruiting | Phase 1 / Phase 2 | 619 | Parabilis Medicines, Inc.INDUSTRY | 2 | Aug 17, 2026 | clinicaltrials |
| NCT06276764 | The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas) | enrolling by invitation | — | 500 | Adenocyte, LLCINDUSTRY | 1 | Aug 6, 2026 | clinicaltrials |
| NCT03729453 | Intra-operative Pancreatoscopy in Patients With IPMN | active not recruiting | — | 100 | Boston Scientific CorporationINDUSTRY | 6 | Jul 24, 2026 | clinicaltrials |
| NCT07703605 | AI-Assisted MRI Molecular Subtyping in Pediatric Brain Tumors | not yet recruiting | — | 1,400 | Huashan HospitalOTHER | 0 | Jul 23, 2026 | clinicaltrials |
| NCT07712328 | Randomized Controlled Clinical Study on the Prophylactic Intraoperative Use of Desmopressin in Complex Sellar Region Tumors(RCT-PIDST) | enrolling by invitation | Phase 4 | 152 | Zhaoyun ZhangOTHER | 1 | Jul 17, 2026 | clinicaltrials |
| NCT07700992 | A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring(PANXEON) | recruiting | — | 600 | Università Vita-Salute San RaffaeleOTHER | 1 | Jul 14, 2026 | clinicaltrials |
| NCT07316101 | Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery | recruiting | N/A | 20 | West China HospitalOTHER | 1 | Jun 30, 2026 | clinicaltrials |
| NCT07659639 | Biophotonic Nanoparticle-enabled Laser Blood Test for Early Detection of Pancreatic Cancer(LASERBLOOD) | recruiting | N/A | 400 | Fondazione Policlinico Universitario Campus Bio-MedicoOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT07657884 | Assessment of the Usefulness of SMI (Superb Vascular Imaging) for the Characterisation of Pancreatic Cystic Tumours (IMAKYST)(IMAKYST) | recruiting | N/A | 60 | GCS Ramsay Santé pour l'Enseignement et la RechercheOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT00840047 | Methionine PET/CT Studies In Patients With Cancer | active not recruiting | Phase 2 | 503 | St. Jude Children's Research HospitalOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT02834013 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | active not recruiting | Phase 2 | 798 | National Cancer Institute (NCI)NIH | 2 | Jun 17, 2026 | clinicaltrials |
| NCT03711890 | Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer | recruiting | N/A | 75 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT03224767 | Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma | active not recruiting | Phase 2 | 24 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jun 10, 2026 | clinicaltrials |
| NCT07621029 | Venous Resection in Patients Undergoing Pancreatic Surgery(VENUS) | not yet recruiting | — | 1,000 | Sahlgrenska University HospitalOTHER | 2 | Jun 2, 2026 | clinicaltrials |
| NCT02757859 | WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer | active not recruiting | N/A | 845 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT07529483 | Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cystic Neoplasms(ERASE-Chemo) | recruiting | Phase 2 | 35 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT04087902 | Long-Term Longitudinal QoL in Patients Undergoing EEA | active not recruiting | — | 400 | Ohio State UniversityOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT06320990 | Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection(MCN_Tam) | recruiting | Phase 1 | 15 | University of NebraskaOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT05233397 | ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma | recruiting | Phase 2 | 30 | Nationwide Children's HospitalOTHER | 3 | Apr 23, 2026 | clinicaltrials |
| NCT05465174 | Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults(PNOC029) | recruiting | Phase 2 | 57 | Sabine Mueller, MD, PhDOTHER | 2 | Apr 23, 2026 | clinicaltrials |
| NCT07536087 | Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Cystic Neoplasms and Pancreatic Neuroendocrine Tumors | recruiting | N/A | 50 | Institute for Clinical and Experimental MedicineOTHER_GOV | 1 | Apr 17, 2026 | clinicaltrials |
| NCT07535125 | IPEX Study: Pancreatic Exocrine Insufficiency as a Functional Marker of Disease Progression in Patients With IPMN(IPEX) | not yet recruiting | — | 600 | A.O.U. Città della Salute e della ScienzaOTHER | 0 | Apr 16, 2026 | clinicaltrials |
| NCT05286788 | MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma | recruiting | Phase 2 | 38 | Nationwide Children's HospitalOTHER | 3 | Apr 8, 2026 | clinicaltrials |
| NCT04622423 | Advanced Therapies for Liver Metastases(LiMeT) | recruiting | — | 625 | IRCCS San RaffaeleOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT03610906 | Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy | enrolling by invitation | — | 250 | University of Colorado, DenverOTHER | 1 | Mar 23, 2026 | clinicaltrials |
| NCT06712797 | Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center(PANTHER-PIC) | active not recruiting | N/A | 24 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT07463872 | Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data | recruiting | — | 500 | Huazhong University of Science and TechnologyOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT07439757 | AI-Powered Precision Decision-Making for Pancreatic Diseases | recruiting | — | 2,000 | Changhai HospitalOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07301554 | Food Preferences and Craniopharyngiomas(PREFAMHYPO) | not yet recruiting | — | 346 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 23, 2026 | clinicaltrials |
| NCT03970226 | Tocilizumab in Children With ACP | active not recruiting | Early Phase 1 | 9 | University of Colorado, DenverOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT03673124 | Ribociclib and Letrozole Treatment in Ovarian Cancer | active not recruiting | Phase 2 | 51 | Gynecologic Oncology GroupNETWORK | 1 | Dec 23, 2025 | clinicaltrials |
| NCT07262957 | Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)(PANENCA) | recruiting | Phase 4 | 400 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT06694792 | Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst bIomarkers Detection (INCITE) Consortium(INCITE) | recruiting | — | 800 | IRCCS San RaffaeleOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT06970145 | Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma | recruiting | Phase 1 / Phase 2 | 57 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT06519097 | Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3) | active not recruiting | Phase 2 | 4 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Nov 13, 2025 | clinicaltrials |
| NCT07216521 | Intent of Surgery for IPMN | recruiting | — | 2,000 | NYU Langone HealthOTHER | 5 | Oct 14, 2025 | clinicaltrials |
| NCT07177482 | ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients | recruiting | N/A | 20 | Deling LiOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT06574373 | Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression | recruiting | — | 3,600 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Sep 3, 2025 | clinicaltrials |
| NCT07117045 | Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer(AI-LDCT-PC) | recruiting | — | 400,000 | Changhai HospitalOTHER | 1 | Aug 12, 2025 | clinicaltrials |
Data updated 20 hours agoSource updated Sep 29, 2026source: clinicaltrials